Notice of intent to sole source BIORAD Test Kits

Closed Solicitation Posted

Solicitation number
NOI_00222
Agency
Responses due
Set-aside
8(a) Sole Source

Opportunity facts

Place of performance
Atlanta, Georgia 30333, United States
Points of contact

Notice details come from SAM.gov. Updated .

About this opportunity

The Centers for Disease Control and Prevention (CDC) intends to award a sole source firm fixed price purchase order to procure BIO-RAD Laboratories INC. test kits. These test kits, including HIV-1/HIV-2 Plus O EIA, Geenius HIV 1/2 Supplemental Assay plus controls, and HIV-1 Western Blot, are needed to strengthen rapid test quality assurance in the international countries being supported. The CDC requires these validated and approved test kits to maintain the integrity and quality of all samples tested and the data provided from the HIV recency projects. Interested parties may identify their interest and capability to respond to the requirement, but this is not a request for competitive quotations. Responses received within seven days of the notice will be considered, but the government has sole discretion on whether to conduct a competitive procurement.

This procurement is set aside for an 8(a) sole source award to BIO-RAD Laboratories, INC., located in Hercules, CA. The anticipated contract value is not provided, but the requirement is for supplies to be delivered to the CDC in Atlanta, GA. The NAICS code is 325414 - Biological Product (except Diagnostic) Manufacturing, and the PSC code is 6640-P - Laboratory Equipment And Supplies.

Notice text

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to procure BIO-RAD Laboratories INC. test kits. These tests will be used to strengthen rapid test quality assurance in the international countries being supported. It is important to report quality data, reduce costs, and prevent/correct any errors in testing.These test kits have been used to validate and verify sample testing in the International Laboratory Branch in Atlanta, GA to maintain integrity and quality of all samples tested. The data provided from the HIV recency projects are important for future planning of HIV control in these PEPFAR countries and therefore needs to be kept to the same standards.

We now need additional kits to use for PEPFAR assay validation and training. These serological test kits and controls from BIO-RAD are validated and meet requirements needed for proper sample collection, sample processing, and sample storage. These requirements are set by the HIV serology team at DGHT/ILB serology and incidence laboratory and also the President’s Emergency Plan for AIDS Relief (PEPFAR) funded labs who participate in the HIV recency projects. In order to maintain the quality of testing and data the same supplies/reagents are required at all labs. This is vital to maintain the integrity and quality of training panels, plasma samples, and testing outcomes of the many international HIV projects.

These test kits shall include HIV-1/HIV-2 Plus O EIA, Geenius HIV 1/2 Supplemental Assay plus controls, and HIV-1 Western Blot. These requirements are set by the HIV serology team at DGHT/ILB serology and incidence laboratory and also the President’s Emergency Plan for AIDS Relief (PEPFAR) funded labs who participate in the HIV serology projects. 

We propose to contract with BIO-RAD Laboratories, INC., located at 2000 Alfred Nobel Drive, Hercules, CA 94547-1801, is identified as a vendor capable of providing the test kits needed. 

This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-l(b) (SAP) and 41 U.S.C. 3304(a). Interested persons may identify their interest and capability to respond to the requirement.

This notice of intent is not a request for competitive quotations; however, all quotations/responses received within seven (7) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at qnt8@cdc.gov by 12pm 05 July 2024.

Notice history

Notice Type Posted
This notice Latest solicitation Solicitation
NOI to Sole Source - Division for Global HIV & Tuberculosis International laboratory Original Pre-Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
Notice of Intent to Sole Source a Thermo Orbitrap Fusion Lumos and Thermo RSLCnano UPLC Maintenance Agreement Georgia 30329, United States · NAICS 811210 CDC Office of Acquisition Services No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity